Brief: Tianjin Teda Biomedical Engineering Agrees To Sell 82.76% Equity Interest In Shanghai Weidi

Tianjin Teda Biomedical Engineering Co

27/03/2024 10:33

March 27 (Reuters) - Tianjin TEDA Biomedical Engineering
Co Ltd  8189.HK :
    * AGREED TO SELL 82.76% EQUITY INTEREST IN SHANGHAI WEIDI
    * DISPOSAL EQUITY OF A WHOLLY-OWNED SUBSIDIARY
    * DISPOSAL FOR RMB10.6 MILLION
    * SEES TO RECORD GAIN OF RMB6.7 MILLION FROM DISPOSAL

Further company coverage:  8189.HK 

 ((Reuters.Briefs@thomsonreuters.com;))